Clinicians should reassure women with endometriosis about the risk of malignancy associated with the use of hormonal contraceptives (Smith et al., 2003; Zucchetto et al., 2009; Gierisch et al., 2013; Havrilesky et al., 2013; Braganza et al., 2014; Berlanda et al., 2016; Wentzensen et al., 2016; Butt et al., 2018; Michels et al., 2018). |
|